Wallachia in the 15th century was an unstable region with many pretenders to the throne, local feuds and external threats ...
Comedy legend Richard Pryor died at age 65 in 2005. Here’s everything to know about Richard Pryor's death and comedic legacy.
News Editor Jasmine Davey explores the life and work of writer, producer and Ricardian, Philippa Langley. Together, they discuss her discovery of Richard III’s remains and her search for Henry I ...
NY Attorney General Letitia James is contesting the authority of U.S. Attorney John Sarcone III in legal proceedings.
A royal expert has told the story of how King Charles once wrote a letter to a former royal employee because of a scandal ...
Bacillus amyloliquefaciens-modified bio-organic fertilizer (BOF) has shown great potential in improving crop yields and soil quality in degraded or reclaimed soils. However, the underlying microbial ...
John R. O'Rourke III does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Bioptix, Inc..
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA ...
An exhibition has been in place temporarily in York since 2024 A permanent exhibition showing a state-of-the-art avatar of King Richard III has opened in Leicester. The display, which features a ...
A permanent exhibition showing a state-of-the-art avatar of King Richard III has opened in Leicester. The display, which features a digital image of the medieval king speaking in a Yorkshire accent, ...
Detailed data will be forthcoming at a scientific congress, but Bayer AG’s positive top-line readout from its phase III study testing oral factor XIa (FXIa) inhibitor asundexian in reducing the risk ...
OCEANIC-STROKE demonstrates superiority of asundexian with antiplatelet therapy, showing significant reduction in ischemic stroke risk, without increasing ISTH major bleeding rate, compared to placebo ...